VUMC researchers found that peptides modified by highly reactive compounds called isolevuglandins activated T cells and promoted hypertension in mice. Their first-ever isolation of such peptides is a step toward potentially intervening in this pathologic process.

The highlight of the ceremony was the presentation of white lab coats to the students. A symbol of academic rigor and scientific excellence, the lab coat also reflects a commitment to benefiting society through research and discovery. 

A multicenter study conducted in 19 states between October 2023 and March 2024 demonstrated that RSV vaccination was 75% effective in preventing RSV-associated hospitalizations for adults age 60 and older.

The research may lead to new treatments for diseases such as inflammatory bowel disease and mucositis, a severe complication of chemotherapy.

How can caregivers be expected to hold the grief of their patients, and their patients’ families, when they are grieving themselves? That was the question addressed at a recent panel discussion at Vanderbilt.

VUMC’s antibody collaboration with the DOD goes back to 2018, when the medical center signed a five-year cooperative agreement with the U.S. Defense Advanced Research Projects Agency to develop protective treatments that can be rushed to health care providers within weeks after a viral outbreak.